{"transactions":[{"id":2288547,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":127774,"kind":"person","name":"Dunn Keary","position":1,"cik":"0001868779","reported_name":"Dunn Keary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-29T01:04:29.000Z","date":"2022-04-13","kind":"grant","acquired":true,"shares":48100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date."}],"balance_after":48100,"derivative":{"exercise_price":10.16,"expiration_date":"2032-04-13","underlying":"Class A Common Stock","underlying_shares":48100},"source":{"system":"sec-edgar","filing":"0000899243-22-015910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000089924322015910/doc4.xml","form_type":"4"}},{"id":2288546,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":127774,"kind":"person","name":"Dunn Keary","position":1,"cik":"0001868779","reported_name":"Dunn Keary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Class A Common Stock","published_at":"2022-04-29T01:04:29.000Z","date":"2022-04-13","kind":"grant","acquired":true,"shares":16405,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock.  The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date."}],"balance_after":16405,"source":{"system":"sec-edgar","filing":"0000899243-22-015910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000089924322015910/doc4.xml","form_type":"4"}},{"id":2571656,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":127774,"kind":"person","name":"Dunn Keary","position":1,"cik":"0001868779","reported_name":"Dunn Keary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & EVP"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-13T22:08:34.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":76859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable as follows: 50% is fully-vested as of the grant date; 50% is subject to time-based vesting over a four-year period from the July 16, 2021 closing of the business combination, with 25% of this tranche vesting on the one-year anniversary of the closing (July 16, 2022), and the remainder vesting monthly thereafter so that vested in full on the four-year anniversary of the business combination closing date, and subject to the Reporting Person's continuous service on each vesting date."}],"balance_after":76859,"derivative":{"exercise_price":10.23,"expiration_date":"2031-09-09","underlying":"Class A Common Stock","underlying_shares":76859},"source":{"system":"sec-edgar","filing":"0001213900-21-047748","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000121390021047748/ownership.xml","form_type":"4"}},{"id":2628892,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":127774,"kind":"person","name":"Dunn Keary","position":1,"cik":"0001868779","reported_name":"Dunn Keary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Business Dev"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-21T01:08:34.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":384297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement and Plan of Merger and Reorganization, dated January 8, 2021 (the \"Business Combination Agreement\"), by and among GX Acquisition Corp. (\"GX\"), Alpha First Merger Sub Corp., Celularity LLC and Celularity Inc. (\"Legacy Celularity\"), each security to purchase shares of Legacy Celularity common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into a security to purchase a number of shares of the Issuer's common stock based on a 1-to-0.768594024295126 conversion ratio. Upon consummation of the business combination, GX changed its name to \"Celularity Inc.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over a period of four years from the Vesting Start Date, March 23, 2020, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date."}],"balance_after":384297,"derivative":{"exercise_price":3.7,"expiration_date":"2031-07-16","underlying":"Class A Common Stock","underlying_shares":384297},"source":{"system":"sec-edgar","filing":"0001209191-21-047508","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000120919121047508/doc4a.xml","form_type":"4/A","original_submission_date":"2021-07-16"}},{"id":2631557,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":127774,"kind":"person","name":"Dunn Keary","position":1,"cik":"0001868779","reported_name":"Dunn Keary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Business Dev"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-16T21:40:32.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":279089,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over a period of four years from the Vesting Start Date, March 23, 2020, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date."}],"balance_after":279089,"derivative":{"exercise_price":2.1829,"expiration_date":"2031-07-16","underlying":"Class A Common Stock","underlying_shares":279089},"source":{"system":"sec-edgar","filing":"0001209191-21-046979","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000120919121046979/doc4.xml","form_type":"4"}},{"id":2631556,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":127774,"kind":"person","name":"Dunn Keary","position":1,"cik":"0001868779","reported_name":"Dunn Keary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Business Dev"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-16T21:40:32.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":105207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over a period of four years from the Vesting Start Date, March 23, 2020, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date."}],"balance_after":105207,"derivative":{"exercise_price":2.1829,"expiration_date":"2031-07-16","underlying":"Class A Common Stock","underlying_shares":105207},"source":{"system":"sec-edgar","filing":"0001209191-21-046979","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000120919121046979/doc4.xml","form_type":"4"}}]}